Jennifer Warneke

Jennifer Warneke serves as the Global Head of Biotech GPL Operations.  Acting as the voice of Parexel Biotech and its Biopharma clients, she partners cross-functionally in the development and implementation of organization wide operational best practices and processes as well as overseeing Biotech delivery.

Prior to joining Parexel, Jennifer served as the Senior Vice President, Clinical Operations for G1 Therapeutics, Inc., an oncology focused biopharmaceutical company. She oversaw clinical operations, data management, and clinical trial supplies. Her experience includes serving as the Senior Vice President Global Oncology Operations at Syneos Health, where she oversaw operational and financial delivery for the oncology business unit, with direct management of its 1400 staff. Prior roles at Syneos Health include Vice President, Oncology Clinical Operations overseeing the oncology clinical operations team; Vice President, Clinical Development, overseeing resource management of the oncology business unit; and Vice President Global Operations Management leading integration workstreams for the merger between InVentiv and INC. Research as well as the evolution of the Trusted Process, Syneos Health’s Operating Model.

Jennifer has over 18 years of pharmaceutical development and CRO experience. She was nominated as a Rising Star member of the Healthcare Businesswomen’s Association (HBA) Class of 2021. She holds a Bachelor of Arts in Communications from Brigham Young University.